Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement
Safe and pragmatic use of SGLT2 inhibitors in type 2 diabetes mellitus: SAFES consensus statement
Executive Summary: Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i)
JPMA Gestational Diabetes Guidelines
